US pharma major Bristol Myers Squibb has stopped development of ORM-6151, a degrader-antibody conjugate (DAC) it licensed ...

US clinical-stage biotech Sironax announced that Novartis has exercised its exclusive option to acquire the full global ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended 7 novel medicines for approval at its September 2026 meeting.

Longeveron, the US biotech developing cellular therapies for rare pediatric and aging-related conditions, saw its shares fall around 59% on Thursday after it reported that its Phase IIb ELPIS II trial ...

Russia is seeking to expand imports of Indian pharmaceuticals as part of a broader push to rebalance bilateral trade and lift volumes to $100 billion by 2030, according to Vladimir Padalko, vice ...

US biopharma company Cullinan Therapeutics notched a Phase III win for its lead oncology asset, zipalertinib, potentially opening a larger first-line commercial opportunity and moving the biotech ...

ST Biotherapeutics, the South Korean biopharmaceutical company known as 1STBIO, has entered an exclusive global licensing agreement and strategic equity investment with SK Biopharmaceuticals to ...

Danish vaccine maker Bavarian Nordic (OMX: BAVA) has named Tarja Stenvall as president and chief executive with effect from October 15, closing a search that opened in March when Paul Chaplin said he ...

German family-owned pain specialist Grünenthal has priced 850 million euros ($974 million) of senior secured notes due 2032, ...

San Diego-based medical device developer Aethlon Medical (Nasdaq: AEMD) has agreed an all-stock merger with privately held US ...

Danish pharma major Novo Nordisk (NOV: N) has struck a multi-target discovery and license agreement with fellow Copenhagen ...

The Indian Patent Office (IPO) has released draft guidelines to strengthen the examination of pharmaceutical patent applications, aiming to improve quality, consistency, and uniformity in scrutiny.